WALTHAM, Mass., March 19 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, intends to pay, to the extent declared, dividends payable April 15, 2009, on its Series B Convertible Perpetual Preferred Stock in shares of Series B stock. Inverness will pay cash in lieu of any fractional shares resulting from the dividend.
For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. Inverness’ global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Inverness is headquartered in Waltham, Massachusetts.
CONTACT: Doug Guarino, Director of Corporate Relations of Inverness
Medical Innovations, Inc., +1-781-647-3900
Web site: http://www.invernessmedical.com
